Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

. Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial. Lancet 2022 Jan 27. pii: S0140-6736(22)00101.
PMID: 35093205


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016